Introduction by the Guest Editor At a Crossroad to Cure From Molecule to Management Strategies in Multiple MyelomaMunshi, Nikhil C., MDThe Cancer Journal: January/February 2019 - Volume 25 - Issue 1 - p 1 doi: 10.1097/PPO.0000000000000357 Review Articles Buy SDC Author InformationAuthors Article MetricsMetrics From the Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, and VA Boston Healthcare System, Harvard Medical School, Boston, MA. Conflicts of Interest and Source of Funding: N.C.M. is a consultant for Celgene, Takeda, Janssen, Oncopep, and Merck. This work was supported by the National Institutes of Health grant P01-155258-07. Reprints: Nikhil C. Munshi, MD, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215. E-mail: Nikhil_munshi@dfci.harvard.edu. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.